Skip to main content

Published locations for Umbralisib gains FDA breakthrough designation for MZL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Umbralisib gains FDA breakthrough designation for MZL

User login

  • Reset your password
  • /content/umbralisib-gains-fda-breakthrough-designation-mzl
  • /hematologynews/article/193303/indolent-lymphoma/umbralisib-gains-fda-breakthrough-designation-mzl
  • /oncologypractice/article/193303/indolent-lymphoma/umbralisib-gains-fda-breakthrough-designation-mzl
  • /hematology-oncology/article/193303/indolent-lymphoma/umbralisib-gains-fda-breakthrough-designation
  • /hematologytimes/article/193303/indolent-lymphoma/umbralisib-gains-fda-breakthrough-designation-mzl